The trademark application PHENOPRINT was filed by Recursion Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 17, 2022, and it was registered by office on January 24, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Change of name and address of the trademark registration was recorded on September 13, 2022.
Goods And Services
The mark was filed in class 9 with Downloadable computer software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds and Recorded computer software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds..
The mark was filed in class 42 with Scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, conducting and evaluating clinical trials and software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds..